These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
82 related items for PubMed ID: 4476662
21. Effects of 5-(n-butyl)-picolinamide (SCH 10595), a dopamine-beta-hydroxylase inhibitor, on serotonin and catecholamine metabolites in brain. Korduba CA, Veals J, Symchowicz S. J Pharmacol Exp Ther; 1974 Sep; 190(3):459-65. PubMed ID: 4413186 [No Abstract] [Full Text] [Related]
22. Selective inhibition of dopamine-beta-hydroxylase in the peripheral tissues by 5-dimethyldithiocarbamylpicolinic acid; its effect on stress-induced ulcer, ethanol-induced sleep and blood pressure. Hidaka H, Hara F, Harada N, Hashizume Y, Yano M. J Pharmacol Exp Ther; 1974 Dec; 191(3):384-92. PubMed ID: 4473535 [No Abstract] [Full Text] [Related]
23. Effects of fusaric (5-butylpicolinic) acid on the monosynaptic reflex neural activity of cat spinal cord. Watanabe Y, Matsumiya T, Oka T. Tokai J Exp Clin Med; 1981 Oct; 6(4):443-51. PubMed ID: 7324082 [Abstract] [Full Text] [Related]
28. Pharmacology of fusaric acid in man. Matta RJ, Wooten GF. Clin Pharmacol Ther; 1973 Jun 15; 14(4):541-6. PubMed ID: 4269210 [No Abstract] [Full Text] [Related]
29. Behavioral depression in Sidman avoidance learning induced by dopamine beta-hydroxylase inhibitors. Tamaki Y, Hidaka H. Psychol Rep; 1976 Apr 15; 38(2):437-8. PubMed ID: 1265176 [No Abstract] [Full Text] [Related]
30. Behavioral effects of a new dopamine-beta-hydroxylase inhibitor (fusaric acid) in man. Goodwin FK, Sack RL. J Psychiatr Res; 1974 Apr 15; 11():211-7. PubMed ID: 4618285 [No Abstract] [Full Text] [Related]
31. Synthesis of 5-(substituted alkyl) picolinic acids. The dopamine beta-hydroxylase inhibitors. II. Miyano K, Sakasai T, Hamano H. Chem Pharm Bull (Tokyo); 1978 Aug 15; 26(8):2328-33. PubMed ID: 709695 [No Abstract] [Full Text] [Related]
32. Fusaric acid-induced elevation of homovanillic acid in the CSF as an index of brain noradrenaline synthesis. Elghozi JL, Laude D, Chaouloff F. Eur J Pharmacol; 1985 Nov 19; 117(3):363-7. PubMed ID: 4076351 [Abstract] [Full Text] [Related]
34. The action of neuroleptics in rats with altered catecholamine metabolism. IV. Behavioral and biochemical effects of chlorpromazine and haloperidol in rats pretreated with inhibitors of dopamine-beta-hydroxylase. Vetulani J. Arch Immunol Ther Exp (Warsz); 1973 Nov 19; 21(3):501-6. PubMed ID: 4730817 [No Abstract] [Full Text] [Related]
38. Central dopamine function in affective illness: evidence from precursors, enzyme inhibitors, and studies of central dopamine turnover. Goodwin FK, Sack RL. Adv Biochem Psychopharmacol; 1974 Apr 19; 12(0):261-79. PubMed ID: 4608958 [No Abstract] [Full Text] [Related]
39. Biology of schizophrenia: Mental effects of dopamine-beta-hydroxylase inhibition in normal men. Hartmann E, Keller-Teschke M. Lancet; 1977 Jan 01; 1(8001):37-8. PubMed ID: 63668 [No Abstract] [Full Text] [Related]
40. Inhibition of dopamine-b-hydroxylase in manic patients. A clinical trial and fusaric acid. Sack RL, Goodwin FK. Arch Gen Psychiatry; 1974 Nov 01; 31(5):649-54. PubMed ID: 4613319 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]